Empliciti (elotuzumab) for the Treatment of Multiple Myeloma
Empliciti’s FDA approval was based on results from the ELOQUENT-2 Phase III clinical study. Image: courtesy of Bristol-Myers Squibb.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry
-
MIT Optimal Sourcing Solutions
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator...
About
MIT Optimal Sourcing Solutions is a dedicated supplier of comparator drugs, specialised in European Union (EU) open market solutions for clinical trials.
FollowMake an Enquiry
-
Kognitic
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust,...
About
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.
FollowMake an Enquiry
